Insider Transactions in Q1 2023 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
5,580
-2.43%
|
$111,600
$20.95 P/Share
|
|
Mar 14
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,792
-1.71%
|
$55,840
$20.95 P/Share
|
|
Mar 06
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
5,580
-2.37%
|
$133,920
$24.71 P/Share
|
|
Mar 06
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,792
-1.68%
|
$67,008
$24.71 P/Share
|
|
Mar 03
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
13,651
-3.55%
|
$327,624
$24.53 P/Share
|
|
Mar 02
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
11,349
-1.44%
|
$261,027
$23.37 P/Share
|
|
Mar 01
2023
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,173
+21.84%
|
$12,346
$2.39 P/Share
|
|
Feb 13
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
607
-0.26%
|
$15,782
$26.26 P/Share
|
|
Feb 13
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
303
-0.18%
|
$7,878
$26.26 P/Share
|
|
Feb 10
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,973
-2.05%
|
$129,298
$26.17 P/Share
|
|
Feb 10
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,489
-1.48%
|
$64,714
$26.17 P/Share
|
|
Feb 02
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,174
-0.64%
|
$144,872
$28.84 P/Share
|
|
Feb 01
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
5,589
-2.25%
|
$150,903
$27.11 P/Share
|
|
Feb 01
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,795
-1.63%
|
$75,465
$27.11 P/Share
|
|
Feb 01
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
19,826
-2.37%
|
$535,302
$27.25 P/Share
|
|
Jan 03
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
5,125
-1.49%
|
$112,750
$22.9 P/Share
|
|
Jan 03
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
3,833
-1.26%
|
$84,326
$22.9 P/Share
|
|
Jan 03
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,704
-1.86%
|
$177,192
$23.18 P/Share
|